Published in Gene Therapy Weekly, October 18th, 2001
However, first, researchers must optimize stem cell transduction. A team at the University of California at San Francisco recently reported their experiences with retroviral transduction using stem cells obtained from the livers of fetuses. Their results suggest that with the right culture conditions, transduced cells remain a viable method for delivering gene therapies targeting birth defects.
Stem cells obtained from the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.